AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Redcare Pharmacy N.V.

Director's Dealing Mar 9, 2021

6219_dirs_2021-03-09_ef4e8835-1300-41b0-9710-100fc6b69640.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 9 March 2021 19:39

DGAP-DD: SHOP APOTHEKE EUROPE N.V. english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

09.03.2021 / 19:38

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name: Stefan
Last name(s): Feltens

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

SHOP APOTHEKE EUROPE N.V.

b) LEI

529900JK6UXHY1YKZ082

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: NL0012044747

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
175.40 EUR 71914.00 EUR
175.20 EUR 24528.00 EUR

d) Aggregated information

Price Aggregated volume
175.3491 EUR 96442.0000 EUR

e) Date of the transaction

2021-03-08; UTC+1

f) Place of the transaction

Name: Xetra
MIC: XETR

09.03.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Internet: www.shop-apotheke-europe.com
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.